Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)
Clinical trial NCT00442936 · COMPLETED
Trial details
- NCT number
- NCT00442936
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-15
- Primary completion
- 2007-10-02
- Enrollment
- 1380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.